| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/16/2002 | WO2002038758A1 Lysate clearance and nucleic acid isolation using silanized silica matrices |
| 05/16/2002 | WO2002038757A1 Method for generating recombinant dna library using unidirectional single-stranded dna fragments |
| 05/16/2002 | WO2002038756A1 Use of mutagenic dna polymerase for producing random mutations |
| 05/16/2002 | WO2002038755A1 Circular extra-chromosomal dna elements |
| 05/16/2002 | WO2002038753A1 Method of screening gene affecting pathological conditions or survival of animal infected with pathogen |
| 05/16/2002 | WO2002038751A2 Ras/p21 transgenic mouse |
| 05/16/2002 | WO2002038750A1 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells |
| 05/16/2002 | WO2002038749A1 Method of anticipating gene network, anticipation system and recording medium |
| 05/16/2002 | WO2002038748A2 Mammalian sex selection using genetic modification |
| 05/16/2002 | WO2002038747A2 Human adenylate cyclase |
| 05/16/2002 | WO2002038745A2 Regulation of mitogen-activated protein kinase (mapk) |
| 05/16/2002 | WO2002038744A2 Proteases |
| 05/16/2002 | WO2002038743A2 Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp |
| 05/16/2002 | WO2002038740A1 Recombinant zymomonas mobilis with improved xylose utilization |
| 05/16/2002 | WO2002038739A1 Bacterial expression systems |
| 05/16/2002 | WO2002038738A2 Chimeric molecules to modulate gene expression |
| 05/16/2002 | WO2002038736A2 Methods for regulating plant gaba production |
| 05/16/2002 | WO2002038733A2 A selectable genetic marker for use in pasteurellaceae species |
| 05/16/2002 | WO2002038732A2 Human testis specific serine/threonine kinase |
| 05/16/2002 | WO2002038730A2 Novel human potassium channel beta subunit |
| 05/16/2002 | WO2002038728A2 Method for removing a universal linker from an oligonucleotide |
| 05/16/2002 | WO2002038727A2 Dna sequences encoding proteins conferring phytophthora infestans resistance on plants |
| 05/16/2002 | WO2002038726A2 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/16/2002 | WO2002038613A2 Modified recombinase |
| 05/16/2002 | WO2002038609A2 Apolipoprotein conjugates |
| 05/16/2002 | WO2002038608A2 Methods of screening for ltrpc2 modulators |
| 05/16/2002 | WO2002038607A2 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | WO2002038606A2 Compositions and methods relating to ovary specific genes and proteins |
| 05/16/2002 | WO2002038605A1 A novel peptide---olfactory receptor 27.61 and the polynucleotide encoding this novel peptide |
| 05/16/2002 | WO2002038604A1 A new polypeptide-cicliary rootlet protein 45.98 and the polynucleotide encoding it |
| 05/16/2002 | WO2002038603A1 A novel peptide---human large protein 1225-13.87 and the polynucleotide coding this novel peptide |
| 05/16/2002 | WO2002038601A2 Foggy |
| 05/16/2002 | WO2002038600A2 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 05/16/2002 | WO2002038599A2 A plant development regulating gene and its uses |
| 05/16/2002 | WO2002038597A2 Genomic fragment of streptococcus suis and clinical uses thereof |
| 05/16/2002 | WO2002038596A1 Method of identifying antibacterial compounds |
| 05/16/2002 | WO2002038594A1 Novel therapeutic compositions for treating infection by lawsonia spp |
| 05/16/2002 | WO2002038593A1 Haemophilus antigen |
| 05/16/2002 | WO2002038589A2 Haplotypes of the cyp2d6 gene |
| 05/16/2002 | WO2002038588A2 Putrescine-n-methyltransferase promoter |
| 05/16/2002 | WO2002038587A2 Haplotypes of the grm8 gene |
| 05/16/2002 | WO2002038585A2 Haplotypes of the gss gene |
| 05/16/2002 | WO2002038580A1 Streptavidin-binding peptides and uses thereof |
| 05/16/2002 | WO2002038578A1 Modified nucleosides and nucleotides and use thereof |
| 05/16/2002 | WO2002038188A2 Use of the human lrp/mvp promotor for a vector that can be induced by therapy |
| 05/16/2002 | WO2002038179A1 Preventives or remedies for endoplasmic reticulum stress-associated diseases |
| 05/16/2002 | WO2002038173A1 Vaccine based on a cellular penetration factor from an apicomplexan parasite |
| 05/16/2002 | WO2002038172A2 Sdf-1 beta expressing tumor cells as tumor vaccines |
| 05/16/2002 | WO2002038171A2 METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE |
| 05/16/2002 | WO2002038108A2 Methods of treating disorders related to apoe |
| 05/16/2002 | WO2002038045A2 Techniques for deriving tissue structure from multiple projection dual-energy x-ray absorptiometry |
| 05/16/2002 | WO2002037967A1 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 05/16/2002 | WO2002037957A2 Transgenic mice containing perk protein kinase gene disruptions |
| 05/16/2002 | WO2002037955A1 Barley with reduced ssii activity and starch containing products with a reduced amylopectin content |
| 05/16/2002 | WO2002037951A1 Monocotyledonous plant transformation |
| 05/16/2002 | WO2002037938A2 Method and device for selectively targeting cells within a three -dimensional specimen |
| 05/16/2002 | WO2002026943A3 Production of virus-like hcv particles in the cells of insects |
| 05/16/2002 | WO2002022839A3 Internal ribosome entry sites (ires) of errantiviruses and uses thereof |
| 05/16/2002 | WO2002022814A3 Nucleotide sequences which code for the atr43 gene |
| 05/16/2002 | WO2002020823A3 Methods and compositions for visualizing and interfering with chromosomal tethering of extrachromosomal molecules |
| 05/16/2002 | WO2002020771A3 Nucleotide sequences coding for the hisc2 gene |
| 05/16/2002 | WO2002020760A3 Human vomeronasal receptor |
| 05/16/2002 | WO2002020725A3 Lnp, a protein involved in the initiation of mycorrhizal infection in plants |
| 05/16/2002 | WO2002020003A3 Use of carp inhibitors for the treatment of heart diseases |
| 05/16/2002 | WO2002019968A3 Genetically engineered co-expression dna vaccines, construction methods and uses thereof |
| 05/16/2002 | WO2002018538A3 PROTOCOLS FOR THE GENERATION OF HIGH YIELD, SUPER-PRODUCTIVE TRANSGENIC PLANTS DISTURBED IN Ran/Ran-BINDING PROTEINS-MEDIATED CELLULAR PROCESS |
| 05/16/2002 | WO2002017902A8 Gene conferring resistance to the antibacterial 4,5-dihydroxy-2-cyclopenten-1-one (dhcp), the protein encoded by same, and applications thereof |
| 05/16/2002 | WO2002016614A8 Identification of a human n-terminal acetyltransferase gene |
| 05/16/2002 | WO2002016424A3 Dna binding peptide domains and a method for providing domains of this type |
| 05/16/2002 | WO2002012539A3 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 05/16/2002 | WO2002006502A3 Adenovirus vectors comprising introns |
| 05/16/2002 | WO2002006499A9 Zmaxig1-specific polynucleotides and methods of use |
| 05/16/2002 | WO2002002806A3 Method and nucleic acids for analysing the methylation of genes implicated in pharmacogenomics |
| 05/16/2002 | WO2002002777A3 Gpsa gene from corynebaxteria and use thereof in synthesis of l-amino acids |
| 05/16/2002 | WO2002002640A3 Antibodies to human mcp-1 |
| 05/16/2002 | WO2002002598A3 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR18, AND USES THEROF |
| 05/16/2002 | WO2002000899A3 Heterologous gene expression in plants |
| 05/16/2002 | WO2001098335A3 Transgenic algae for delivering antigens to an animal |
| 05/16/2002 | WO2001096593A3 Novel motor proteins and methods for their use |
| 05/16/2002 | WO2001096395A3 Biosynthetic oncolytic molecules and uses therefor |
| 05/16/2002 | WO2001094629A8 Cancer gene determination and therapeutic screening using signature gene sets |
| 05/16/2002 | WO2001092496A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/16/2002 | WO2001092469A3 Phosphorylated polypeptides and uses related thereto |
| 05/16/2002 | WO2001092291A3 Antibody and t-cell receptor libraries |
| 05/16/2002 | WO2001090313A3 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS |
| 05/16/2002 | WO2001090183A3 Human secreted protein, zsig47 |
| 05/16/2002 | WO2001088533A3 Lipid uptake assays |
| 05/16/2002 | WO2001088157A3 Treatment methods using 17906 and uses therefor |
| 05/16/2002 | WO2001086003A8 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human lung |
| 05/16/2002 | WO2001085965A3 Vectors for use in transposon-based dna sequencing methods |
| 05/16/2002 | WO2001085933A3 Plakoglobin interacting proteins |
| 05/16/2002 | WO2001085913A3 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa |
| 05/16/2002 | WO2001085789A3 Extracellular domain of ryk protein for regulating angiogenesis |
| 05/16/2002 | WO2001083547A3 Anti-inflammatory compounds and uses thereof |
| 05/16/2002 | WO2001081622A8 Diagnosis of diseases associated with dna repair |
| 05/16/2002 | WO2001081599A3 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 05/16/2002 | WO2001081405A3 Methods and compositions for the prevention and treatment of anemia |
| 05/16/2002 | WO2001081368A3 Blood-pressure reducing polypeptides containing vpp derived from microorganisms |
| 05/16/2002 | WO2001080810A3 Chondroitin synthase gene and methods of making and using same |
| 05/16/2002 | WO2001079549A3 CONSTRUCTION OF UNI-DIRECTIONALLY CLONED cDNA LIBRARIES FROM MESSENGER RNA FOR IMPROVED 3'END DNA SEQUENCING |